カテゴリ： Allied Market Research, 世界, 医療/バイオ

患者血液管理のグローバル市場（2021〜2031）：器具、付属品、試薬・キット、ソフトウェア

■ 英語タイトル：Patient Blood Management Market By Product (Instruments, Accessories, Reagents and Kits, Software), By Component (Whole Blood and Red Blood Cells, Plasma), By End User (Blood Banks, Hospitals, Diagnostic Clinics and Pathology Labs): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23MA058）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23MA058
■ 発行日：2022年12月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：240
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[患者血液管理のグローバル市場（2021〜2031）：器具、付属品、試薬・キット、ソフトウェア]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本調査レポートによると、2021年に122億ドルであった世界の患者血液管理市場規模が、2031年までに221億ドルに達し、2022年から2031年の間に年平均6.3%で成長すると予測されています。本書は、患者血液管理の世界市場について調査し、市場動向や今後の展望をまとめた資料です。イントロダクション、エグゼクティブサマリー、市場概要、製品別（器具、付属品、試薬・キット、ソフトウェア）分析、コンポーネント別（全血・赤血球、血漿）分析、エンドユーザー別（血液バンク、病院、診断クリニック・病理検査室）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況、企業情報など、以下の構成で掲載しています。本書内には、Grifols, S.A.、B. Braun SE、Immucor, Inc、Haemonetics Corporation、LivaNova PLC、Biomerieux SA、Haier Biomedical、Macopharma、Terumo Corporation、Asahi Kasei Corporationなど、主な参入企業情報が含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の患者血液管理市場規模：製品別
- 器具の市場規模
- 付属品の市場規模
- 試薬・キットの市場規模
- ソフトウェアの市場規模
・世界の患者血液管理市場規模：コンポーネント別
- 全血・赤血球における市場規模
- 血漿における市場規模
・世界の患者血液管理市場規模：エンドユーザー別
- 血液バンクにおける市場規模
- 病院における市場規模
- 診断クリニック・病理検査室における市場規模
・世界の患者血液管理市場規模：地域別
- 北米の患者血液管理市場規模
- ヨーロッパの患者血液管理市場規模
- アジア太平洋の患者血液管理市場規模
- 中南米・中東・アフリカの患者血液管理市場規模
・競争状況
・企業情報

患者血液管理は、輸血を必要とする可能性のある患者をケアするための、エビデンスに基づいた集学的アプローチです。患者血液管理は、最初の患者評価から臨床管理まで、輸血の意思決定プロセスのあらゆる側面を含みます。これらの手法は、患者の転帰を最適なものにすると同時に、血液供給量を維持し、血液成分が必要なときに患者のために利用できるようにすることを目的としています。

患者血液管理は、患者自身の血液を増加させ保存する方法で患者の医学的および外科的管理を改善することにより、患者の転帰を改善します。管理が改善されることで、患者は通常、提供された血液成分の輸血を必要とする回数が減り、輸血に関連する合併症を避けることができます。オーストラリア国家血液局は、エビデンスに基づく患者血液管理ガイドラインの開発に資金を提供し、管理しています。
患者血液管理市場の成長を促進する主な要因としては、患者血液管理装置の技術的進歩の増加、世界人口における血液疾患の有病率の増加、献血者数の急増などが挙げられます。さらに、血液がんの有病率の上昇、マラリアやがんなどの疾患の有病率の増加がこの市場の成長を促進します。例えば、白血病リンパ腫協会のデータによると、2021年に米国で新たに発生した白血病、リンパ腫、骨髄腫の症例は、推定1,898,160件のがん症例の9.8%を占めています。
しかし、患者の血液管理に使用される器具や機器のコストが高いだけでなく、不利な償還が市場成長の妨げになると予想されます。それとは反対に、発展途上国における満たされていない医療需要と新興国における有利なビジネスチャンスは、将来的に世界中の患者血液管理装置メーカーに計り知れない機会をもたらすと予想されています。

さらに、慢性疾患の増加や外科手術件数の増加により、ヘルスケア事業が成長し、患者血液管理市場の成長を後押しすると予測されています。さらに、失血を引き起こす交通事故の増加、献血に関する意識の高まり、医療に対する政府支出の増加が、患者血液管理市場の成長を後押ししています。このため、主要企業は予測期間中に同市場へ投資する有益な機会を得られると予想されます。
また、安全で効果的な患者用血液管理装置の発見・開発における研究開発投資の増加、先進国における資本所得の大幅な増加、主要企業が採用する製品発売、提携、合併・買収などの主要戦略の増加は、市場における患者用血液管理装置の需要を強化します。
例えば、2019年7月、世界的なヘルスケア企業であり、血漿由来医薬品の生産者であるGrifols社は、同国における救命血漿医薬品の利用可能性を高めるという同社のコミットメントの一環として、カナダ初の献血センターの買収を発表しました。Grifols Canada Therapeutics社は株式売買契約により、ウィニペグにあるPrometic Plasma Resources社（PPR）の献血センターをKedrion社から現金400万米ドルで買収しました。PPRは、市販の競合システムよりも狭いスペースで効率的に血液や血漿をスクリーニングできるように設計されています。多くの時間を必要とする検査において、アリニティの自動化と柔軟性は、血液・血漿センターの生産性向上と最高レベルの精度維持に貢献すると期待されています。したがって、このような要因が患者血液管理市場の成長を促進します。

患者血液管理市場は、製品、コンポーネント、エンドユーザー、地域によって区分されます。製品別では、機器（血液処理機器、輸血機器、血液培養スクリーニング機器、診断・検査機器、血液保存機器）、付属品（注射器・針、バイアル・チューブ、血液バッグ、その他）、試薬・キット（血液培養培地、血液型検査試薬、スライド染色試薬、アッセイキット）、ソフトウェアに分類されます。成分別では、全血・赤血球、血漿に分類されます。エンドユーザー別では、病院、血液銀行、診断クリニック・病理研究所に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域）、アジア太平洋地域（中国、日本、オーストラリア、インド、その他のアジア太平洋地域）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他のLAMEA地域）に市場を分けて分析しています。

本レポートに掲載されている主要企業は、B. Braun SE、BioMérieux, Inc.、Grifols, S.A.、Haemonetics Corporation、Haier Biomedical、Immucor, Inc.、LivaNova PLC、Macopharma、旭化成株式会社、テルモ株式会社などです。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの患者血液管理市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、患者血液管理市場の有力な市場機会を特定します。
・市場調査は、主要な促進要因、阻害要因、機会に関する情報とともに提供されます。
・ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるように、バイヤーとサプライヤーの潜在力を強調します。
・患者血液管理市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・本レポートでは、地域別および世界の患者血液管理市場の動向、主要企業、市場セグメント、応用分野、市場成長戦略などの分析を掲載しています。

〈主要市場セグメント〉
成分別
全血＆赤血球
血漿

エンドユーザー別
血液銀行
病院
診断クリニック＆病理検査室

製品別
・機器
血液処理装置
輸血用機器
血液培養検査装置
診断＆検査機器
血液保存装置
・付属品
シリンジ＆注射針
バイアル＆チューブ
血液バッグ
その他
・試薬・キット
血液培養培地
血液型検査試薬
スライド染色試薬
アッセイキット
・ソフトウェア

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
中国
日本
インド
オーストラリア
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Grifols, S.A.
B. Braun SE
Immucor, Inc
Haemonetics Corporation
LivaNova PLC
Biomerieux SA
Haier Biomedical
Macopharma
テルモ株式会社
旭化成株式会社

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. High bargaining power of suppliers
3.3.2. High bargaining power of buyers
3.3.3. High threat of substitutes
3.3.4. High threat of new entrants
3.3.5. High intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in incidence of trauma and accidents
3.4.1.2. Increase in prevalence of blood cancer
3.4.1.3. Increase in government expenditure on healthcare

3.4.2. Restraints
3.4.2.1. Risks related to blood transfusion procedure
3.4.2.2. High cost of advanced patient blood management products

3.4.3. Opportunities
3.4.3.1. Rise in demand for blood and other blood related products across the globe
3.4.3.2. Surge in blood donations and plasma donations across the globe

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Instruments
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Instruments Patient Blood Management Market by Type
4.2.4.1. Blood Processing Devices Market size and forecast, by region
4.2.4.2. Blood Transfusion Devices Market size and forecast, by region
4.2.4.3. Blood Culture Screening Devices Market size and forecast, by region
4.2.4.4. Diagnostic and Testing Instruments Market size and forecast, by region
4.2.4.5. Blood Storage Devices Market size and forecast, by region
4.3. Accessories
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Accessories Patient Blood Management Market by Type
4.3.4.1. Syringes and Needles Market size and forecast, by region
4.3.4.2. Vials and Tubes Market size and forecast, by region
4.3.4.3. Blood Bags Market size and forecast, by region
4.3.4.4. Others Market size and forecast, by region
4.4. Reagents and Kits
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.4.4. Reagents and Kits Patient Blood Management Market by Type
4.4.4.1. Blood Culture Media Market size and forecast, by region
4.4.4.2. Blood Typing Reagents Market size and forecast, by region
4.4.4.3. Slide Staining Reagents Market size and forecast, by region
4.4.4.4. Assay Kits Market size and forecast, by region
4.5. Software
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT
5.1. Overview
5.1.1. Market size and forecast
5.2. Whole Blood and Red Blood Cells
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Plasma
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: PATIENT BLOOD MANAGEMENT MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Blood Banks
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Hospitals
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Diagnostic Clinics and Pathology Labs
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PATIENT BLOOD MANAGEMENT MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.2.1. North America Instruments Patient Blood Management Market by Type
7.2.2.2. North America Accessories Patient Blood Management Market by Type
7.2.2.3. North America Reagents and Kits Patient Blood Management Market by Type
7.2.3. Market size and forecast, by Component
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Component
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Component
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Component
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.2.1. Europe Instruments Patient Blood Management Market by Type
7.3.2.2. Europe Accessories Patient Blood Management Market by Type
7.3.2.3. Europe Reagents and Kits Patient Blood Management Market by Type
7.3.3. Market size and forecast, by Component
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Component
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Component
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Component
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Component
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Component
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Component
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.2.1. Asia-Pacific Instruments Patient Blood Management Market by Type
7.4.2.2. Asia-Pacific Accessories Patient Blood Management Market by Type
7.4.2.3. Asia-Pacific Reagents and Kits Patient Blood Management Market by Type
7.4.3. Market size and forecast, by Component
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Component
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. Japan
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Component
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Component
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Component
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. Rest of Asia-Pacific
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Component
7.4.5.5.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.2.1. LAMEA Instruments Patient Blood Management Market by Type
7.5.2.2. LAMEA Accessories Patient Blood Management Market by Type
7.5.2.3. LAMEA Reagents and Kits Patient Blood Management Market by Type
7.5.3. Market size and forecast, by Component
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Component
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Component
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product
7.5.5.3.3. Market size and forecast, by Component
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product
7.5.5.4.3. Market size and forecast, by Component
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Asahi Kasei Corporation
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. B. Braun SE
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Biomerieux SA
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Grifols, S.A.
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Haemonetics Corporation
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Haier Biomedical
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Immucor, Inc
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. LivaNova PLC
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. Macopharma
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Terumo Corporation
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 02. PATIENT BLOOD MANAGEMENT MARKET FOR INSTRUMENTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 03. GLOBAL INSTRUMENTS PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 04. PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD PROCESSING DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 05. PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD TRANSFUSION DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 06. PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD CULTURE SCREENING DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 07. PATIENT BLOOD MANAGEMENT MARKET FOR DIAGNOSTIC AND TESTING INSTRUMENTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 08. PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD STORAGE DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 09. PATIENT BLOOD MANAGEMENT MARKET FOR ACCESSORIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. GLOBAL ACCESSORIES PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 11. PATIENT BLOOD MANAGEMENT MARKET FOR SYRINGES AND NEEDLES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. PATIENT BLOOD MANAGEMENT MARKET FOR VIALS AND TUBES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD BAGS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 14. PATIENT BLOOD MANAGEMENT MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. PATIENT BLOOD MANAGEMENT MARKET FOR REAGENTS AND KITS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 16. GLOBAL REAGENTS AND KITS PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 17. PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD CULTURE MEDIA, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 18. PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD TYPING REAGENTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. PATIENT BLOOD MANAGEMENT MARKET FOR SLIDE STAINING REAGENTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 20. PATIENT BLOOD MANAGEMENT MARKET FOR ASSAY KITS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 21. PATIENT BLOOD MANAGEMENT MARKET FOR SOFTWARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 22. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 23. PATIENT BLOOD MANAGEMENT MARKET FOR WHOLE BLOOD AND RED BLOOD CELLS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 24. PATIENT BLOOD MANAGEMENT MARKET FOR PLASMA, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 25. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 26. PATIENT BLOOD MANAGEMENT MARKET FOR BLOOD BANKS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 27. PATIENT BLOOD MANAGEMENT MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 28. PATIENT BLOOD MANAGEMENT MARKET FOR DIAGNOSTIC CLINICS AND PATHOLOGY LABS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 29. PATIENT BLOOD MANAGEMENT MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 30. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 31. NORTH AMERICA INSTRUMENTS PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 32. NORTH AMERICA ACCESSORIES PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. NORTH AMERICA REAGENTS AND KITS PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 34. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 35. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 36. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 37. U.S. PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 38. U.S. PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 39. U.S. PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 40. CANADA PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 41. CANADA PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 42. CANADA PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 43. MEXICO PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 44. MEXICO PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 45. MEXICO PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 46. EUROPE PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 47. EUROPE INSTRUMENTS PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 48. EUROPE ACCESSORIES PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. EUROPE REAGENTS AND KITS PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 50. EUROPE PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 51. EUROPE PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 52. EUROPE PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 53. GERMANY PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 54. GERMANY PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 55. GERMANY PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 56. FRANCE PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 57. FRANCE PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 58. FRANCE PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 59. UK PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 60. UK PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 61. UK PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 62. ITALY PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 63. ITALY PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 64. ITALY PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 65. SPAIN PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 66. SPAIN PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 67. SPAIN PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 68. REST OF EUROPE PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 69. REST OF EUROPE PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 70. REST OF EUROPE PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 71. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 72. ASIA-PACIFIC INSTRUMENTS PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 73. ASIA-PACIFIC ACCESSORIES PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. ASIA-PACIFIC REAGENTS AND KITS PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 75. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 76. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 77. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 78. CHINA PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 79. CHINA PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 80. CHINA PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 81. JAPAN PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 82. JAPAN PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 83. JAPAN PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 84. INDIA PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 85. INDIA PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 86. INDIA PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 87. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 88. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 89. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 90. REST OF ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 91. REST OF ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 92. REST OF ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 93. LAMEA PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 94. LAMEA INSTRUMENTS PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 95. LAMEA ACCESSORIES PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 96. LAMEA REAGENTS AND KITS PATIENT BLOOD MANAGEMENT MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 97. LAMEA PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 98. LAMEA PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 99. LAMEA PATIENT BLOOD MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 100. BRAZIL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 101. BRAZIL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 102. BRAZIL PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 103. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 104. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 105. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 106. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 107. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 108. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 109. REST OF LAMEA PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 110. REST OF LAMEA PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 111. REST OF LAMEA PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 112. ASAHI KASEI CORPORATION: KEY EXECUTIVES
TABLE 113. ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
TABLE 114. ASAHI KASEI CORPORATION: PRODUCT SEGMENTS
TABLE 115. ASAHI KASEI CORPORATION: PRODUCT PORTFOLIO
TABLE 116. B. BRAUN SE: KEY EXECUTIVES
TABLE 117. B. BRAUN SE: COMPANY SNAPSHOT
TABLE 118. B. BRAUN SE: PRODUCT SEGMENTS
TABLE 119. B. BRAUN SE: PRODUCT PORTFOLIO
TABLE 120. BIOMERIEUX SA: KEY EXECUTIVES
TABLE 121. BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 122. BIOMERIEUX SA: PRODUCT SEGMENTS
TABLE 123. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 124. GRIFOLS, S.A.: KEY EXECUTIVES
TABLE 125. GRIFOLS, S.A.: COMPANY SNAPSHOT
TABLE 126. GRIFOLS, S.A.: PRODUCT SEGMENTS
TABLE 127. GRIFOLS, S.A.: PRODUCT PORTFOLIO
TABLE 128. GRIFOLS, S.A.: KEY STRATERGIES
TABLE 129. HAEMONETICS CORPORATION: KEY EXECUTIVES
TABLE 130. HAEMONETICS CORPORATION: COMPANY SNAPSHOT
TABLE 131. HAEMONETICS CORPORATION: PRODUCT SEGMENTS
TABLE 132. HAEMONETICS CORPORATION: PRODUCT PORTFOLIO
TABLE 133. HAEMONETICS CORPORATION: KEY STRATERGIES
TABLE 134. HAIER BIOMEDICAL: KEY EXECUTIVES
TABLE 135. HAIER BIOMEDICAL: COMPANY SNAPSHOT
TABLE 136. HAIER BIOMEDICAL: PRODUCT SEGMENTS
TABLE 137. HAIER BIOMEDICAL: PRODUCT PORTFOLIO
TABLE 138. IMMUCOR, INC: KEY EXECUTIVES
TABLE 139. IMMUCOR, INC: COMPANY SNAPSHOT
TABLE 140. IMMUCOR, INC: PRODUCT SEGMENTS
TABLE 141. IMMUCOR, INC: PRODUCT PORTFOLIO
TABLE 142. LIVANOVA PLC: KEY EXECUTIVES
TABLE 143. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 144. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 145. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 146. MACOPHARMA: KEY EXECUTIVES
TABLE 147. MACOPHARMA: COMPANY SNAPSHOT
TABLE 148. MACOPHARMA: PRODUCT SEGMENTS
TABLE 149. MACOPHARMA: PRODUCT PORTFOLIO
TABLE 150. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 151. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 152. TERUMO CORPORATION: PRODUCT SEGMENTS
TABLE 153. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 154. TERUMO CORPORATION: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 患者血液管理のグローバル市場（2022年-2029年）：機器付属品、試薬＆キット、ソフトウェア
  • ケアマネジメントソリューションのグローバル市場（2021〜2031）：ソフトウェア、サービス
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23MA058 )"患者血液管理のグローバル市場（2021〜2031）：器具、付属品、試薬・キット、ソフトウェア" (英文：Patient Blood Management Market By Product (Instruments, Accessories, Reagents and Kits, Software), By Component (Whole Blood and Red Blood Cells, Plasma), By End User (Blood Banks, Hospitals, Diagnostic Clinics and Pathology Labs): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。